Enhancing the Therapeutic Delivery of Oligonucleotides by Chemical Modification and Nanoparticle Encapsulation

被引:37
|
作者
Sun, Yating [1 ]
Zhao, Yarong [1 ]
Zhao, Xiuting [1 ]
Lee, Robert J. [1 ,2 ]
Teng, Lesheng [1 ]
Zhou, Chenguang [3 ]
机构
[1] Jilin Univ, Sch Life Sci, Changchun 130012, Jilin, Peoples R China
[2] Ohio State Univ, Coll Pharm, 500 W 12Th Ave, Columbus, OH 43210 USA
[3] Tavistock Life Sci, San Diego, CA 92130 USA
关键词
oligonucleotide; siRNA; miRNA; antisense; nanocarriers; TYROSINE KINASE INHIBITOR; SIRNA DELIVERY; IN-VITRO; ANTISENSE OLIGONUCLEOTIDES; CO-DELIVERY; POLYMERIC NANOPARTICLES; INTRACELLULAR DELIVERY; LOADED NANOBUBBLES; GOLD NANOPARTICLES; TARGETED DELIVERY;
D O I
10.3390/molecules22101724
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Oligonucleotide (ON) drugs, including small interfering RNA (siRNA), microRNA (miRNA) and antisense oligonucleotides, are promising therapeutic agents. However, their low membrane permeability and sensitivity to nucleases present challenges to in vivo delivery. Chemical modifications of the ON offer a potential solution to improve the stability and efficacy of ON drugs. Combined with nanoparticle encapsulation, delivery at the site of action and gene silencing activity of chemically modified ON drugs can be further enhanced. In the present review, several types of ON drugs, selection of chemical modification, and nanoparticle-based delivery systems to deliver these ON drugs are discussed.
引用
收藏
页数:26
相关论文
共 50 条
  • [21] Enhancing nanoparticle catalysis for chemical transformations
    Sun, Shouheng
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2018, 256
  • [22] Therapeutic oligonucleotides and delivery technologies: Research topics in Japan
    Murakami, Masahiro
    DRUG DISCOVERIES AND THERAPEUTICS, 2016, 10 (05): : 234 - +
  • [23] Antisense oligonucleotides: local delivery enhances their therapeutic potential
    Nyce, JW
    EXPERT OPINION ON THERAPEUTIC PATENTS, 1999, 9 (03) : 263 - 267
  • [24] ENCAPSULATION OF CURCUMIN IN SILVER NANOPARTICLE FOR ENHANCEMENT OF ANTICANCER DRUG DELIVERY
    Garg, S.
    Garg, A.
    INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH, 2018, 9 (03): : 1160 - 1166
  • [25] Chemical modification and design of anti-miRNA oligonucleotides
    K A Lennox
    M A Behlke
    Gene Therapy, 2011, 18 : 1111 - 1120
  • [26] Application of unnatural oligonucleotides to chemical modification of gene expression
    Sasaki, Shigeki
    Nagatsugi, Fumi
    CURRENT OPINION IN CHEMICAL BIOLOGY, 2006, 10 (06) : 615 - 621
  • [27] Chemical modification and design of anti-miRNA oligonucleotides
    Lennox, K. A.
    Behlke, M. A.
    GENE THERAPY, 2011, 18 (12) : 1111 - 1120
  • [28] DELIVERY OF ANTISENSE OLIGONUCLEOTIDES BY POLY(L-LYSINE) CONJUGATION AND LIPOSOME ENCAPSULATION
    CLARENC, JP
    DEGOLS, G
    LEONETTI, JP
    MILHAUD, P
    LEBLEU, B
    ANTI-CANCER DRUG DESIGN, 1993, 8 (01): : 81 - 94
  • [29] Enhancing the therapeutic efficacy of CpG oligonucleotides using biodegradable microparticles
    Malyala, Padma
    O'Hagan, Derek T.
    Singh, Manmohan
    ADVANCED DRUG DELIVERY REVIEWS, 2009, 61 (03) : 218 - 225
  • [30] Nanoparticle-Patterned Multicompartmental Chitosan Capsules for Oral Delivery of Oligonucleotides
    Kim, Taehyung
    Kim, Jeong Un
    Yang, Kyungjik
    Nam, Keonwook
    Choe, Deokyeong
    Kim, Eugene
    Hong, Il-Hwa
    Song, Minjung
    Lee, Hyunah
    Park, Jiyong
    Roh, Young Hoon
    ACS BIOMATERIALS SCIENCE & ENGINEERING, 2018, 4 (12): : 4163 - 4173